L559-0229 Screening compound: 3-{[2-(2-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidine-2,4-dione

L559-0229 Screening compound: 3-{[2-(2-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidine-2,4-dione
L559-0229 Screening compound: 3-{[2-(2-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidine-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound L559-0229
3-{[2-(2-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidine-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L559-0229

Molecular Formula

C24H20N6O4 (C24 H20 N6 O4)

Compound Name

3-{[2-(2-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidine-2,4-dione

IUPAC name

3-{[2-(2-methoxyphenyl)-5-methyl-13-oxazol-4-yl]methyl}-1-methyl-7-(pyridin-3-yl)-1H2H3H4H-[13]diazino[45-d]pyrimidine-24-dione

SMILES

Cc1c(CN(C(c2c(N3C)nc(-c4cnccc4)nc2)=O)C3=O)nc(-c(cccc2)c2OC)o1

InChI

InChI=1S/C24H20N6O4/c1-14-18(27-22(34-14)16-8-4-5-9-19(16)33-3)13-30-23(31)17-12-26-20(15-7-6-10-25-11-15)28-21(17)29(2)24(30)32/h4-12H,13H2,1-3H3

InChI Key

SDRLMCXBESTEDX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27462007

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.46

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.436

Distribution Coefficient, logD

1.072

Water Solubility, LogSw

-2.42

Polar Surface Area

86.679

Acid Dissociation Constant (pKa)

26.85

Base Dissociation Constant (pKb)

8.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

L559-0229 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L559-0229 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L559-0229?
Check Price and Availability of L559-0229, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L559-0229 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L559-0229
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L559-0229
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L559-0229 available by request